
Dr. Benjamin H. Krasne, M.D.
Board-certified physicianBoard-certified in anesthesiology, he reads medications and metabolism with a pharmacologist's eye, which shapes how he doses weight loss and longevity care.
Weight loss
GLP-1 shots, daily pills and non-GLP-1 options, prescribed after a free visit.
Start here
Brand-name injections
Pills and other options
Tap your state
State rules change what we can offer and how fast. Pick yours.
ESA and PSD letters, semaglutide, tirzepatide and medical card pages for every state we serve.
Popular ESA cities
Mobile IV in California
PT-141 for low desire, prescribed online
PT-141 acts in the brain on desire and arousal rather than on blood flow. After a short visit, a licensed clinician decides whether a compounded troche that dissolves in your mouth is suitable for you. The price is $149.
Free to book. You pay only if you go ahead with treatment.
PT-141 acts on brain pathways linked to desire and arousal, unlike ED pills that act on blood flow. Your clinician explains which fits your concern.
A licensed U.S. clinician reviews your blood pressure, heart health and medicines before prescribing, since PT-141 can raise blood pressure for hours.
The troche dissolves between your cheek and gum or under your tongue. It is compounded by a licensed U.S. pharmacy and is not FDA-approved.
You get written guidance on timing and monthly limits, plus follow-up for nausea or other side effects and plain-packaged delivery.
Pick a phone or video slot online. There is no fee for the first consultation and no insurance requirement.
In about 5–10 minutes, a licensed clinician asks about your desire, relationship context, blood pressure, heart history, skin and medicines.
If PT-141 suits you, the clinician prescribes a starting dose and explains timing, how often you may use it and what to watch for.
Report nausea, flushing or skin changes. Your clinician can adjust the dose or suggest another approach if it is not working for you.
You would like to want sex more, and the problem is desire or arousal rather than physical function alone.
Erections improve with medicine, but interest has not. Your clinician may consider PT-141 alongside an ED treatment.
Women whose low desire is new and bothersome may be candidates, after other causes such as medicines, mood or relationship stress are considered.
PT-141 can raise blood pressure, so it is not for people with uncontrolled high blood pressure or known heart disease.
Do not use PT-141 if you are pregnant, and stop it if you become pregnant. Tell your clinician if pregnancy is possible.
| Feature | PT-141 troche | Vyleesi injection | Sildenafil or tadalafil |
|---|---|---|---|
| Main target | Desire and arousal | Desire and arousal | Erection blood flow |
| Form | Dissolving troche | Under-the-skin injection | Tablet |
| FDA status | Compounded, not FDA-approved | FDA-approved for premenopausal women | FDA-approved for ED |
| Who it's used for | Men and women, off-label | Premenopausal women with HSDD | Men with ED |
| Price here | $149 | — | Plans from $39/mo |
PT-141 is the research name for bremelanotide, a peptide that activates melanocortin receptors in the brain. These receptors are involved in sexual motivation, which is why bremelanotide is studied as a treatment for low desire rather than for the mechanics of sex. That sets it apart from ED pills such as sildenafil and tadalafil, which act on blood flow once arousal has already started.
In 2019, the FDA approved bremelanotide as an under-the-skin injection (brand name Vyleesi) for premenopausal women with hypoactive sexual desire disorder, meaning low desire that is recent, distressing and not explained by another medical, mental health or relationship cause. The FDA-approved label does not cover men or women after menopause, so prescribing for those groups is off-label.
The troche offered here is a small lozenge that dissolves between the cheek and gum or under the tongue. It is made by a licensed U.S. compounding pharmacy and is not FDA-approved. The FDA has not reviewed compounded troches for safety, effectiveness or quality. Your clinician will explain what that means and help you weigh it against other options.
Place the troche where your clinician directs, usually under the tongue or between cheek and gum, and let it dissolve completely without chewing or swallowing it. Peptides like bremelanotide are broken down in the stomach, so absorption through the lining of the mouth is the point of this form.
PT-141 is taken as needed before expected intimacy, not on a schedule. The FDA-approved injection is labeled for use at least 45 minutes beforehand, no more than once in 24 hours and no more than eight times a month. Your clinician will give you limits for the troche that follow the same cautious approach.
The two kinds of medicine solve different problems, and some men use both under a clinician's guidance.
In the clinical trials behind the FDA-approved injection, bremelanotide produced a modest average improvement in desire and related distress compared with placebo, and many participants did not respond. The troche form has not been through the same trials. If you do not notice a change after several uses over about two months, it is reasonable to stop and talk about other options.
PT-141 is not for everyone. Your clinician will screen for heart and blood pressure issues before prescribing and will review your other medicines.
Independently licensed U.S. physicians supervise every treatment we offer.

Board-certified in anesthesiology, he reads medications and metabolism with a pharmacologist's eye, which shapes how he doses weight loss and longevity care.

Trained at Columbia and Washington University, he pairs prescriptions with practical habits around food, training and sleep.

An OB-GYN for more than 40 years and a Fellow of ACOG, she leads women's health care, from perimenopause to PCOS.
Still deciding? The first consultation is free and takes about 5–10 minutes.
Book a free consultationPT-141 is another name for bremelanotide, a peptide that acts on melanocortin receptors in the brain linked to sexual desire. It is used to address low interest or arousal rather than blood flow.
Bremelanotide is FDA-approved only as an injection called Vyleesi, for premenopausal women with low sexual desire. Compounded PT-141 troches are not FDA-approved, and use in men or after menopause is off-label.
PT-141 troches are $149. The first consultation is free and you do not need insurance.
Clinicians sometimes prescribe it off-label for men with low desire, sometimes alongside an ED pill. The FDA-approved product is not labeled for men, so your clinician will discuss the evidence and risks with you.
The FDA-approved injection is used at least 45 minutes beforehand. Your clinician will give you a timing window for the troche, which may differ slightly.
Only as needed, no more than once in 24 hours, and within a monthly limit your clinician sets. Frequent use raises the risk of skin darkening.
Nausea is the most common side effect and is often strongest with the first dose. It tends to ease with later doses. Tell your clinician if it does not.
Often, yes, because it works through a different pathway than most antidepressants. Your clinician will still check your full medicine list before prescribing.
Clinicians sometimes combine them when both desire and erections are concerns. Because one can raise blood pressure and the other can lower it, only combine them with your clinician's approval.
PT-141 is not a hormone and is not known to change testosterone or estrogen levels. If low hormones might be part of the picture, your clinician can suggest testing.
Not always. Reports with the FDA-approved product describe darkening that may persist after stopping, so limit use to what your clinician recommends and report any new dark patches.
Many people do not respond. If several uses bring no change, your clinician can look at other causes of low desire, such as medicines, mood, sleep or hormones, and suggest alternatives.
Yes. PT-141 should only be used under a licensed clinician's care. Products sold online without a prescription may not contain what the label says.
Book a free 5–10 minute phone or video visit. If PT-141 is suitable, a licensed clinician prescribes compounded troches for $149, shipped in plain packaging.
Medically reviewed October 2026. This page is general information and not a substitute for advice from your own clinician. Read our editorial policy.